The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Scheduling (national classification system) (12)
- (-) Weight loss products (4)
- Advertising (115)
- Regulatory compliance (79)
- Prescription medicines (75)
- COVID-19 (70)
- Therapeutic goods regulation (60)
- Listed medicines (48)
- Non-prescription medicines (47)
- Legislation (46)
- COVID-19 vaccines (36)
- Complementary medicines (28)
- Manufacturing (27)
- Medicine safety (27)
- Vaping hub (26)
- Assessed listed medicines (25)
- Australian Register of Therapeutic Goods (ARTG) (16)
- Labelling and packaging (16)
- Compliance and enforcement hub (15)
- Over the counter (OTC) medicines (15)
- Medicinal cannabis hub (13)
- Import and export (11)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Safety (10)
- Medical devices safety (9)
- Alert/Advisory (8)
- Advisory bodies and committees (5)
- Shortages (4)
- Clinical trials (3)
- Sunscreens (3)
- Advanced therapies (1)
- Biological medicines (1)
- Blood and blood components (1)
- Cosmetics (1)
- Fees and payments (1)
- Prescription opioids hub (1)
- Registered complementary medicines (1)
Search
16 result(s) found, displaying 1 to 16
-
Compliance undertakingsWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Media releasesWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.
-
NoticesThis instrument is the Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024.
-
NewsFind out about changes to choline salicylate access, starting from October 2023.
-
NewsStay updated about the commencement of MDMA and psilocybin for the treatment of certain mental illnesses.
-
Media releasesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
-
Media releasesFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
-
NewsSupplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.
-
Media releasesThe TGA has today published an interim decision to reduce the maximum pack sizes for various paracetamol products.
-
Media releasesThe TGA has published an independent expert report examining the incidence of serious injury and death from intentional paracetamol overdose.
-
NoticesThis labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations